Analysis on the risk of diabetes mellitus related to immune checkpoint inhibitors based on the US FDA Adverse Event Reporting System

Peng Jing, Wu Mingli, Ren Xiaolei, Jiang Kaijie, Li Lanfang, Liu Zhen, Wei Tiantian, Meng Luhua, Wang Meixia, Ban Bo

PDF(431 KB)
PDF(431 KB)
Adverse Drug Reactions Journal ›› 2022, Vol. 24 ›› Issue (3) : 123-129. DOI: 10.3760/cma.j.cn114015-20211022-01092

Analysis on the risk of diabetes mellitus related to immune checkpoint inhibitors based on the US FDA Adverse Event Reporting System

    {{javascript:window.custom_author_en_index=0;}}
  • {{article.zuoZhe_EN}}
Author information +
History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

QR code of this article

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations
{{article.zuoZheEn_L}}. {{article.title_en}}. {{journal.qiKanMingCheng_EN}}. 2022, 24(3): 123-129 https://doi.org/10.3760/cma.j.cn114015-20211022-01092

References

Publishing order | Descend order by publishing year | Descend order by cited within

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}
{{article.copyrightLicense_en}}
PDF(431 KB)

Accesses

Citation

Detail
Sections
Recommended

/

〈 〉